Watch Demo

Greece Anti Rheumatic Industry Outlook 2022 - 2026

See how Greece Anti Rheumatic performed compared to key markets such as South Korea, Germany and Spain.

Key Market Indicators

Sales of Greek antirheumatic medicine are forecast to total $45.32 million by 2026, a decrease of 6% annually from 2021's $66.11 million. Since 2003, the Greek market has been declining at a rate of 2.1% each year. The country ranked 12th in 2021, with Chile taking the top spot at $66.11 million. Germany, Spain and Canada followed in second, third and fourth place respectively.

Marketing Banner

Greece Anti Rheumatic Market Data and Forecasts

How much will Greece Anti Rheumatic Market grow to 2026?

Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Greece
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Greece
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Greece
More in Anti Rheumatic Industry for 2028